Contractor
OTSUKA AMERICA PHARMACEUTICAL INC
ROCKVILLE, MD
- UEI
- QKABLBMA8FT9
- Parent UEI
- E5UFBQ3BX3X7
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$682,4921
Awards
5
Agencies served
1
Active from Mar 6, 2026 to Jul 30, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36C24526N0783 JYNARQUE 45MG, 15 MG | Department of Veterans Affairs | FL | Jul 30, 2026 | $20,378 |
| 36E79725A0011 PRODUCT ADD - VOYXACT | Department of Veterans Affairs | — | Jul 10, 2026 | — |
| 36C26124N0298 DE-OB 612A40007 FOR CLOSEOUT. | Department of Veterans Affairs | MD | Jul 9, 2026 | $24,411 |
| 36F79720D0099 TEMPORARY CONTRACT EXTENSION TCE | Department of Veterans Affairs | — | Mar 6, 2026 | — |
| 36C26025F0007 JYNARQUE - BULK- 2025 PRICE INCREASE | Department of Veterans Affairs | FL | Mar 6, 2026 | $637,703 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier QKABLBMA8FT9, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.